Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


15.04.2019

3 Anticancer Res
1 Cancer Lett
2 Hum Pathol
1 Int J Cancer
1 Int J Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. YOSHIDA Y, Beppu T, Kinoshita K, Sato N, et al
    Five-year Recurrence-free Survival After Surgery Followed by Oral Chemotherapy for Gastric Cancer With Portal Vein Tumor Thrombosis.
    Anticancer Res. 2019;39:2233-2238.
    PubMed     Text format     Abstract available

  2. SEO AN, Kang BW, Bae HI, Kwon OK, et al
    Exon 9 Mutation of PIK3CA Associated With Poor Survival in Patients With Epstein-Barr Virus-associated Gastric Cancer.
    Anticancer Res. 2019;39:2145-2154.
    PubMed     Text format     Abstract available

  3. LIU JB, Jian T, Yue C, Chen D, et al
    Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
    Anticancer Res. 2019;39:1689-1698.
    PubMed     Text format     Abstract available


    Cancer Lett

  4. ZHAI J, Shen J, Xie G, Wu J, et al
    Cancer-associated Fibroblasts-derived IL-8 Mediates Resistance to Cisplatin in Human Gastric Cancer.
    Cancer Lett. 2019 Apr 9. pii: S0304-3835(19)30227.
    PubMed     Text format     Abstract available


    Hum Pathol

  5. WEN KW, Grenert JP, Joseph NM, Shafizadeh N, et al
    Genomic profile of appendiceal goblet cell carcinoid is distinct compared to appendiceal neuroendocrine tumor and conventional adenocarcinoma.
    Hum Pathol. 2018;77:166-174.
    PubMed     Text format     Abstract available

  6. WANG F, Wu J, Qiu Z, Ge X, et al
    ACOT1 expression is associated with poor prognosis in gastric adenocarcinoma.
    Hum Pathol. 2018;77:35-44.
    PubMed     Text format     Abstract available


    Int J Cancer

  7. CHEN Z, Liu Z, Zhang M, Huang W, et al
    EPHA2 blockade reverses acquired resistance to afatinib induced by EPHA2-mediated MAPK pathway activation in gastric cancer cells and avatar mice.
    Int J Cancer. 2019 Apr 7. doi: 10.1002/ijc.32313.
    PubMed     Text format     Abstract available


    Int J Oncol

  8. AN C, Li H, Zhang X, Wang J, et al
    Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway.
    Int J Oncol. 2019 Feb 18. doi: 10.3892/ijo.2019.4717.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: